tiprankstipranks
Pulse Biosciences Enhances Board with Strategic Leadership Changes
Company Announcements

Pulse Biosciences Enhances Board with Strategic Leadership Changes

Don't Miss Our Christmas Offers:

The latest announcement is out from Pulse Biosciences (PLSE).

Pulse Biosciences, Inc. has made significant board changes, electing Paul A. LaViolette as a director and appointing him to various leadership roles, including co-chairman and head of the new Strategic Advisory Committee. LaViolette, a seasoned healthcare executive with 40 years of experience, also received stock options as part of his non-employee director compensation. The company revised its compensation policy for non-employee directors, enhancing cash and equity compensation to align with their increased responsibilities and committee service.

For an in-depth examination of PLSE stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyPulse announces publication of nano-PFA Cardiac Surgical System data
TipRanks Auto-Generated NewsdeskPulse Biosciences CEO Resigns Amid Leadership Transition
TipRanks Auto-Generated NewsdeskPulse Biosciences’ Co-Chairman Plans Major Stock Purchase
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App